Hsa_circ_0006010 and hsa_circ_0002903 in peripheral blood serve as novel diagnostic, surveillance and prognostic biomarkers for disease progression in chronic myeloid leukemia
Our study demonstrated that PB levels of hsa_circ_0006010 and hsa_circ_0002903 may serve as novel diagnostic, surveillance, and prognostic biomarkers for CML disease progression and may contribute to assisting in the diagnosis of CML patients at risk for progression and accurate management of advanced CML patients.
Authors
- Zhanguo Chen (ORCID: https://orcid.org/0000-0002-6664-7750)
- Guiling Yan (ORCID: https://orcid.org/0000-0002-0435-2981)
- Xiaoqun Zheng (ORCID: https://orcid.org/0000-0002-9816-4833)
- Yuanyuan Bai (ORCID: https://orcid.org/0000-0001-6180-5417)
- Guiran Wang
- Hongshuang Li (ORCID: https://orcid.org/0000-0002-1740-8876)
- Jingwei Zhao
- Mengting Zheng
Institutions
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
- Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-09-20
- DOI
- https://doi.org/10.1186/s12885-024-12943-x
- Primary Topic
- Circular RNAs in diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00